INTRODUCTION: There is increasing evidence that removal or disconnection of hypothalamic hamartomas can lead to seizure control and improvement in behavior. The purpose of this study is to report our experiences with endoscopic removal of these hamartomas. METHODS: This is a prospective review of the early outcome of 44 patients undergoing endoscopic resection utilizing frameless stereotaxis and a micromanipulator. RESULTS: All patients had normal-sized ventricles. Complete removal was possible in 14 patients, 13 of whom were seizure free at follow-up. Four patients suffered complications that have persisted for more than 3 months: One had significant hemiparesis and three had persistent difficulties with short-term memory. Postoperatively, no patient suffered a permanent hormonal deficiency. In one patient who had undergone a previous attempt at transcallosal resection, the procedure was abandoned because of the lack of internal anatomic landmarks. In a second patient, insufficient mass could be removed due to the size of the lesion and the distorted anatomy. Consequently, 1 week later, the patient underwent a transcallosal approach. CONCLUSION: In appropriately selected patients, sessile hypothalamic hamartomas can be removed completely or they can be completely disconnected from the hypothalamus with an acceptable risk. At least a year after surgery is needed to evaluate the efficacy of the procedure in terms of control of seizures and improvements in behavior and emotional ability.
INTRODUCTION: There is increasing evidence that removal or disconnection of hypothalamic hamartomas can lead to seizure control and improvement in behavior. The purpose of this study is to report our experiences with endoscopic removal of these hamartomas. METHODS: This is a prospective review of the early outcome of 44 patients undergoing endoscopic resection utilizing frameless stereotaxis and a micromanipulator. RESULTS: All patients had normal-sized ventricles. Complete removal was possible in 14 patients, 13 of whom were seizure free at follow-up. Four patients suffered complications that have persisted for more than 3 months: One had significant hemiparesis and three had persistent difficulties with short-term memory. Postoperatively, no patient suffered a permanent hormonal deficiency. In one patient who had undergone a previous attempt at transcallosal resection, the procedure was abandoned because of the lack of internal anatomic landmarks. In a second patient, insufficient mass could be removed due to the size of the lesion and the distorted anatomy. Consequently, 1 week later, the patient underwent a transcallosal approach. CONCLUSION: In appropriately selected patients, sessile hypothalamic hamartomas can be removed completely or they can be completely disconnected from the hypothalamus with an acceptable risk. At least a year after surgery is needed to evaluate the efficacy of the procedure in terms of control of seizures and improvements in behavior and emotional ability.
Authors: Rungsak Siwanuwatn; Pushpa Deshmukh; Iman Feiz-Erfan; Harold L Rekate; Joseph M Zabramski; Robert F Spetzler; Jeffrey V Rosenfeld Journal: Neurosurgery Date: 2005-04 Impact factor: 4.654
Authors: Y Fujimoto; A Kato; Y Saitoh; H Ninomiya; K Imai; N Hashimoto; H Kishima; M Maruno; T Yoshimine Journal: Minim Invasive Neurosurg Date: 2005-06
Authors: J Régis; F Bartolomei; B de Toffol; P Genton; T Kobayashi; Y Mori; K Takakura; T Hori; H Inoue; O Schröttner; G Pendl; A Wolf; K Arita; P Chauvel Journal: Neurosurgery Date: 2000-12 Impact factor: 4.654
Authors: Samuel F Berkovic; Alexis Arzimanoglou; Ruben Kuzniecky; A Simon Harvey; Andre Palmini; Frederick Andermann Journal: Epilepsia Date: 2003-07 Impact factor: 5.864
Authors: Eric Prince; Shahin Hakimian; Andrew L Ko; Jeffrey G Ojemann; Michelle S Kim; John W Miller Journal: Curr Neurol Neurosci Rep Date: 2017-09 Impact factor: 5.081
Authors: S Chibbaro; H Cebula; J Scholly; J Todeschi; I Ollivier; A Timofeev; M Ganau; P Di Emidio; M P Valenti; A M Staack; T Bast; B J Steinhoff; E Hirsch; P Kehrli; F Proust Journal: Neurosurg Rev Date: 2017-02-07 Impact factor: 3.042
Authors: Adib A Abla; Harold L Rekate; David A Wilson; Scott D Wait; Timothy D Uschold; Erin Prenger; Yu-Tze Ng; Peter Nakaji; John F Kerrigan Journal: Childs Nerv Syst Date: 2010-08-10 Impact factor: 1.475
Authors: M Andrew; J R Parr; R Stacey; J V Rosenfeld; Y Hart; P Pretorius; S Nijhawan; Z Zaiwalla; M A McShane Journal: Childs Nerv Syst Date: 2007-09-09 Impact factor: 1.475